CL2014000163A1 - Procedimiento de obtencion de una composicion que contiene factores de crecimiento a partir de plaquetas; composición que compre de factores de crecimiento. - Google Patents

Procedimiento de obtencion de una composicion que contiene factores de crecimiento a partir de plaquetas; composición que compre de factores de crecimiento.

Info

Publication number
CL2014000163A1
CL2014000163A1 CL2014000163A CL2014000163A CL2014000163A1 CL 2014000163 A1 CL2014000163 A1 CL 2014000163A1 CL 2014000163 A CL2014000163 A CL 2014000163A CL 2014000163 A CL2014000163 A CL 2014000163A CL 2014000163 A1 CL2014000163 A1 CL 2014000163A1
Authority
CL
Chile
Prior art keywords
composition
growth factors
platelets
buy
procedure
Prior art date
Application number
CL2014000163A
Other languages
English (en)
Inventor
Aldecoa Eduardo Anitua
Original Assignee
Aldecoa Eduardo Anitua
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aldecoa Eduardo Anitua filed Critical Aldecoa Eduardo Anitua
Publication of CL2014000163A1 publication Critical patent/CL2014000163A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CL2014000163A 2011-07-29 2014-01-21 Procedimiento de obtencion de una composicion que contiene factores de crecimiento a partir de plaquetas; composición que compre de factores de crecimiento. CL2014000163A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201100867A ES2369945B1 (es) 2011-07-29 2011-07-29 Procedimiento de obtención de una composición que contiene factores de crecimiento a partir de un compuesto sanguíneo, y composición obtenible por dicho procedimiento.

Publications (1)

Publication Number Publication Date
CL2014000163A1 true CL2014000163A1 (es) 2014-08-01

Family

ID=44996381

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014000163A CL2014000163A1 (es) 2011-07-29 2014-01-21 Procedimiento de obtencion de una composicion que contiene factores de crecimiento a partir de plaquetas; composición que compre de factores de crecimiento.

Country Status (16)

Country Link
US (1) US8993733B2 (es)
EP (1) EP2740486A1 (es)
JP (1) JP2014521629A (es)
KR (1) KR20140057244A (es)
CN (1) CN103702679B (es)
AR (1) AR087374A1 (es)
BR (1) BR112014001539A2 (es)
CA (1) CA2839973A1 (es)
CL (1) CL2014000163A1 (es)
CO (1) CO6862109A2 (es)
ES (1) ES2369945B1 (es)
MX (1) MX2014000936A (es)
PE (1) PE20141264A1 (es)
RU (1) RU2014102729A (es)
TW (1) TW201309310A (es)
WO (1) WO2013017707A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2442242B1 (es) * 2012-08-09 2014-11-25 Biotechnology Institute, I Mas D, S.L. Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación.
ES2527967B1 (es) * 2013-08-01 2015-12-28 Biotechnology Institute, I Mas D, S.L. Formulación de una composición sanguínea rica en plaquetas y/o factores de crecimiento, con proteínas gelificadas y método de preparación de la misma
US10105306B2 (en) * 2013-09-17 2018-10-23 Bestop Group Holdings Limited Method of preparing a growth factor concentrate
HK1194912A2 (en) * 2013-09-17 2014-10-24 Bestop Group Holdings Ltd Growth factor concentrate and the use thereof
CA2950659A1 (en) * 2016-12-06 2018-06-06 Antnor Limited Method for the preparation and prolonged storage of growth factors and cytokines obtained from platelet rich plasma
JP7110360B2 (ja) 2017-10-09 2022-08-01 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥方法
JP6391872B1 (ja) * 2018-03-30 2018-09-19 セルソース株式会社 成長因子混合物およびその調製方法
ES2778798B2 (es) * 2019-02-11 2021-10-13 Biotechnology Inst I Mas D Sl Formulacion o adhesivo tisular obtenida de una composicion sanguinea que contiene plaquetas, y metodo de preparacion de dicha formulacion
ES2782723B2 (es) * 2019-03-13 2021-05-18 Active Bioregeneration Tech Sl Procedimiento para obtencion y conservacion de factores de crecimiento de alta pureza y sus usos
CN113597532B (zh) 2019-03-14 2023-02-17 泰尔茂比司特生物技术有限公司 冻干容器填充固定装置、系统及使用方法
EP3881858A1 (en) * 2020-03-20 2021-09-22 Rok Pangersic Heat-treated platelet-derived growth factor extract for use in a method of preventing or treating a tissue defect
WO2025184489A1 (en) 2024-02-29 2025-09-04 Consano Bio, Inc. Allogeneic human plasma and platelet derived products and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871997A (en) * 1994-07-21 1999-02-16 Alexion Pharmaceuticals, Inc. Methods and compositions for protecting retroviral vector particles and producer cells from inactivation by complement via reduction of the expression or recognition of galactose alpha (1,3) galactosyl epitopes
AR022333A1 (es) * 1999-01-26 2002-09-04 Anitua Aldecoa Eduardo Regenerador de tejido oseo
WO2002101412A2 (en) * 2001-06-08 2002-12-19 Powderject Vaccines, Inc. Spray freeze-dried compositions
US20030068416A1 (en) * 2001-09-24 2003-04-10 Wilson Burgess Method of lyophylization to reduce solvent content and enhance product recovery
ES2221770B2 (es) 2002-04-19 2006-07-16 Eduardo Anitua Aldecoa Metodo de preparacion de un compuesto para la regeneracion de tejidos.
US20060004189A1 (en) * 2004-07-02 2006-01-05 James Gandy Compositions for treating wounds and processes for their preparation
US20060142198A1 (en) * 2004-07-02 2006-06-29 Wound Care Partners Llc Compositions for treating wounds and processes for their preparation
US7931919B2 (en) * 2005-08-12 2011-04-26 The United States Of America As Represented By The Secretary Of The Army Method of producing glycine-stabilized, lyophilized plasma
JP2008109866A (ja) * 2006-10-30 2008-05-15 Jms Co Ltd 培地添加剤、この培地添加剤を含む培地、及びこの培地を用いた細胞の培養方法
JP2010513462A (ja) * 2006-12-20 2010-04-30 バイエル・ヘルスケア・エルエルシー 第ＶＩＩおよび第ＶＩＩａ因子組成物
EP2133086A4 (en) * 2007-03-07 2011-11-30 Jms Co Ltd PROCESS FOR PREPARING SERUM AND APPARATUS FOR PREPARING SERUM
JP2009050297A (ja) * 2007-08-23 2009-03-12 Tokyo Medical & Dental Univ 脱細胞処理液、脱細胞化組織の調製方法、移植片、及び培養部材
EP2077118A1 (en) * 2008-01-07 2009-07-08 Gwo Rei Biomedical Technology Corp. Clottable concentrate of platelet growth factors and preparation method thereof
US20110268960A1 (en) 2008-07-31 2011-11-03 Jorge Enrique Celis Marin Fire-restrictive arrangement in reinforced plastic ships
CA2761603C (en) 2009-05-14 2018-06-05 Biotechnology Institute, I Mas D, S.L. Method for the preparation of at least one compound from blood, and extraction device for use in the execution of said method
JP2012530721A (ja) * 2009-06-18 2012-12-06 ワイス・エルエルシー 小モジュール免疫薬のための凍結乾燥製剤
JP2013039036A (ja) * 2009-12-16 2013-02-28 Kyowa Hakko Kirin Co Ltd ＨＩＦ−２αの発現を抑制する核酸

Also Published As

Publication number Publication date
KR20140057244A (ko) 2014-05-12
PE20141264A1 (es) 2014-10-09
EP2740486A1 (en) 2014-06-11
ES2369945A1 (es) 2011-12-09
CN103702679A (zh) 2014-04-02
RU2014102729A (ru) 2015-09-10
BR112014001539A2 (pt) 2017-02-14
US8993733B2 (en) 2015-03-31
AR087374A1 (es) 2014-03-19
CO6862109A2 (es) 2014-02-10
CN103702679B (zh) 2016-06-01
TW201309310A (zh) 2013-03-01
CA2839973A1 (en) 2013-02-07
ES2369945B1 (es) 2012-10-15
MX2014000936A (es) 2014-04-30
WO2013017707A1 (es) 2013-02-07
JP2014521629A (ja) 2014-08-28
US20130030161A1 (en) 2013-01-31

Similar Documents

Publication Publication Date Title
CL2014000163A1 (es) Procedimiento de obtencion de una composicion que contiene factores de crecimiento a partir de plaquetas; composición que compre de factores de crecimiento.
ITMI20120889A1 (it) Procedimento per la determinazione di una traiettoria di parcheggio
CL2014002053A1 (es) Composición pesticida que comprende un compuesto derivado de una hidrazinacarbotioamida; y proceso de aplicación.
IT1399831B1 (it) Macchina per realizzare imballi.
UA22559S (uk) Упаковка для сигарет
CO6980625A2 (es) Composiciones que generan perácidos
BR112013015810A2 (pt) método de fabricação de embalagens.
DK2661243T3 (da) Konstruktioner, opnåede ved vævsteknologi
CL2014001960A1 (es) Metodo para producir una composición que contiene galacto-oligosacáridos.
CL2013000831A1 (es) Metodo para la determinacion del contenido de alergenos de una composicion.
IL222975A0 (en) Method for dental pulp cryopreservation
CL2013000688A1 (es) Procedimiento para obtener una composicion de igg a partir de una composicion de igg parcialmente purificada.
FR2964038B1 (fr) Sterilisateur a vapeur pour biberons
EP2793858A4 (en) NATURAL COMPOSITIONS FOR MULTIPLE RELEASE AND RE-USE
ES1075594Y (es) Mesa fabricada a partir de una cuba o barrica
IT1402204B1 (it) Procedimento per la fabbricazione di una cerniera lampo.
CL2013000171A1 (es) Metodo para producir una composicion que comprende uno o mas galacto-oligosacáridos.
ES1073538Y (es) Taloneta con apertura para planta de calzado
UA21063S (uk) Упакування для взуття
PL2780128T3 (pl) Wkładka skrawająca
EM18584990003S (es) Tijeras de poda
UA21964S (uk) Упаковка для сигарет
UA21899S (uk) Упаковка для сигарет
UA22324S (uk) Упаковка для сигарет
UA22670S (uk) Упакування для сигарет